Effects of propofol on cancer development and chemotherapy: Potential mechanisms

被引：92

作者：

Jiang, Sufang ^{[1
]}

Liu, Ya ^{[1
]}

Huang, Lining ^{[1
]}

Zhang, Fuzhen ^{[1
]}

Kang, Rongtian ^{[1
]}

机构：

[1] Hebei Med Univ, Dept Anesthesiol, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2018年 / 831卷

关键词：

Propofol; miRNAs; Signaling pathways; Chemotherapy; Cancer; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA CELLS; NONCODING RNA HOTAIR; PANCREATIC-CANCER; IN-VITRO; SUPPRESSES PROLIFERATION; INHIBITS INVASION; UP-REGULATION; GEMCITABINE RESISTANCE; ANESTHETIC TECHNIQUE;

D O I：

10.1016/j.ejphar.2018.04.009

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Propofol (2, 6-diisopropylphenol) is the commonly used intravenous sedative-hypnotic agent. Accumulating evidence shows that propofol affects cancer development by direct and indirect ways. In this review, we will provide an overview of the effects of propofol on cancer development and chemotherapy, with a special focus on the underlying molecular mechanisms involved. Propofol regulates both microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), and serves as a regulator of different signaling pathways including hypoxia-inducible factor-1 alpha (HIF-1 alpha), mitogen-activated protein kinase (MAPK), nuclear factor-kappaB (NF-kappa B), and nuclear factor E2-related factor-2 (Nrf2) pathways. In addition, propofol modulates host immune function. Possible correlation between propofol and cancer should be verified in further studies, including animal trials and prospective clinical studies.

引用

页码：46 / 51

页数：6

共 85 条

[1] MicroRNAs in the Regulation of MMPs and Metastasis [J].

Abba, Mohammed ;

Patil, Nitin ;

Allgayer, Heike .

CANCERS, 2014, 6 (02) :625-645

[2] An Undesired Effect of Chemotherapy GEMCITABINE PROMOTES PANCREATIC CANCER CELL INVASIVENESS THROUGH REACTIVE OXYGEN SPECIES-DEPENDENT, NUCLEAR FACTOR κB- AND HYPOXIA-INDUCIBLE FACTOR 1α-MEDIATED UP-REGULATION OF CXCR4 [J].

Arora, Sumit ;

Bhardwaj, Arun ;

Singh, Seema ;

Srivastava, Sanjeev K. ;

McClellan, Steven ;

Nirodi, Chaitanya S. ;

Piazza, Gary A. ;

Grizzle, William E. ;

Owen, Laurie B. ;

Singh, Ajay P. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (29) :21197-21207

[3] Anesthesia and cancer recurrences: The current knowledge and evidence [J].

Bajwa, Sukhminder Jit Singh ;

Anand, Smriti ;

Kaur, Gurpreet .

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (03) :528-534

[4]

Bani MR, 2004, MOL CANCER THER, V3, P111

[5] MicroRNAs: Target Recognition and Regulatory Functions [J].

Bartel, David P. .

CELL, 2009, 136 (02) :215-233

[6] LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer [J].

Bhan, Arunoday ;

Mandal, Subhrangsu S. .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2015, 1856 (01) :151-164

[7] Anesthetic technique for radical prostatectomy surgery affects cancer recurrence - A retrospective analysis [J].

Biki, Barbara ;

Mascha, Edward ;

Moriarty, Denis C. ;

Fitzpatrick, John M. ;

Sessler, Daniel I. ;

Buggy, Donal J. .

ANESTHESIOLOGY, 2008, 109 (02) :180-187

[8] Gemcitabine resistance in pancreatic ductal adenocarcinoma [J].

Binenbaum, Yoav ;

Na'ara, Shorook ;

Gil, Ziv .

DRUG RESISTANCE UPDATES, 2015, 23 :55-68

[9] The Role of MicroRNA-200 in Progression of Human Colorectal and Breast Cancer [J].

Bojmar, Linda ;

Karlsson, Elin ;

Ellegard, Sander ;

Olsson, Hans ;

Bjornsson, Bergthor ;

Hallbook, Olof ;

Larsson, Marie ;

Stal, Olle ;

Sandstrom, Per .

PLOS ONE, 2013, 8 (12)

[10] Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines:: an absolute requirement for transcription factor NF-κB [J].

Bond, M ;

Fabunmi, RP ;

Baker, AH ;

Newby, AC .

FEBS LETTERS, 1998, 435 (01) :29-34

← 1 2 3 4 5 6 7 8 9 →